Roivant Sciences Ltd. Quarterly Operating Income (Loss) in USD from Q2 2020 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Roivant Sciences Ltd. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q2 2024.
Roivant Sciences Ltd. Operating Income (Loss) for the quarter ending June 30, 2024 was -$120M, a 56.5% increase year-over-year.
Roivant Sciences Ltd. Operating Income (Loss) for the twelve months ending June 30, 2024 was $4.4B.
Roivant Sciences Ltd. annual Operating Income (Loss) for 2023 was $4.24B.
Roivant Sciences Ltd. annual Operating Income (Loss) for 2022 was -$1.18B, a 13% increase from 2021.
Roivant Sciences Ltd. annual Operating Income (Loss) for 2021 was -$1.35B, a 26.2% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$4.4B	-$120M	+$156M	+56.5%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-09
Q1 2024	$4.24B	-$266M	-$31.8M	-13.6%	Jan 1, 2024	Mar 31, 2024	10-K	2024-05-30
Q4 2023	$4.27B	$5.06B	+$5.44B		Oct 1, 2023	Dec 31, 2023	10-Q	2024-02-13
Q3 2023	-$1.17B	-$276M	+$4.31M	+1.54%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	-$1.17B	-$276M	+$5.9M	+2.09%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-09
Q1 2023	-$1.18B	-$234M	+$32.6M	+12.2%	Jan 1, 2023	Mar 31, 2023	10-K	2024-05-30
Q4 2022	-$1.21B	-$378M	-$132M	-53.7%	Oct 1, 2022	Dec 31, 2022	10-Q	2024-02-13
Q3 2022	-$1.08B	-$281M	+$404M	+59%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13
Q2 2022	-$1.48B	-$282M	-$128M	-82.9%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-14
Q1 2022	-$1.35B	-$267M	+$274M	+50.7%	Jan 1, 2022	Mar 31, 2022	10-K	2023-06-28
Q4 2021	-$1.63B	-$246M	+$13M	+5.04%	Oct 1, 2021	Dec 31, 2021	10-Q	2023-02-13
Q3 2021	-$1.64B	-$684M	-$528M	-337%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	-$1.11B	-$154M	-$39.9M	-34.9%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-15
Q1 2021	-$1.07B	-$541M			Jan 1, 2021	Mar 31, 2021	10-K	2022-06-28
Q4 2020		-$259M			Oct 1, 2020	Dec 31, 2020	10-Q	2022-02-14
Q3 2020		-$157M			Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-15
Q2 2020		-$114M			Apr 1, 2020	Jun 30, 2020	10-Q	2021-09-21

* An asterisk sign (*) next to the value indicates that the value is likely invalid.